Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Powder filling
Capsugel's Xcelodose S system offers automated, programmable, and precise metering of drug powder into capsules or other containers by weight. The unit allows companies to fill capsules with drug substances alone, thereby eliminating the need for excipient compatibility and preformulation activities. The device weighs doses as low as 100 μg and greater than 100 mg with an accuracy of < 2%. Capsugel, Greenwood, SC http://www.capsugel.com/ tel. 800.845.6973



Tablet press
Specialty Measurement offers the MiniTab press, which is designed to manufacture tablets ranging from 0.5 to 4 mm in diameter. The introduction model can produce < 300,000 tablets/h; larger models will be capable of making > 2 million tablets/h. The compact size of the machine, less than 250 500 500 mm, makes it ideal for glove-box applications. SMI, Lebanon, NJ http://www.smitmc.com/ tel. 908.534.1546



Single-use solutions
The FlexAct system focuses on biomanufacturing unit operations and can be used with preconfigured single-use equipment for upstream and downstream processing steps. The system allows users of stainless-steel equipment or individual disposable components to convert to single-use unit operations. Sartorius Stedim Biotech, Bohemia, NY http://www.sartorius-stedim.com/ tel. 800.368.7178



Weldable tubing
PureWeld weldable thermoplastic elastomer (TPE) tubing is suitable for biopharmaceutical processes from research to production. The product is designed to produce a quick, secure, and connector-free fluid path. The TPE contains no animal-derived material that could leach into products. Each piece of tubing displays its lot number and expiration date. Watson-Marlow, Wilmington, MA http://www.watson-marlow.com/ tel. 800.282.8823


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here